WebMay 10, 2024 · By Ian Bezek, InvestorPlace Contributor May 10, 2024, 6:00 am EDT. Ocugen (NASDAQ: OCGN) stock was a late entrant into the Covid-19 vaccine race. OCGN stock traded for less than $1 per share ... WebJun 10, 2024 · Ocugen said the decision was based on a recommendation from the U.S. Food and Drug Administration (FDA), which also requested more information and data …
Ocugen, Inc. (OCGN) Stock Price, News, Quote & History - Yahoo …
WebWHO approval is near !!! ⏳⏳ $ OCGN🚀🚀🤑🤑 This will be the first catalyst !!! Soon after, other news will come out that will further increase the title such as the sale of the vaccine in Canada and North America. First step $ 20/25 with WHO approval then it will continue to rise with other news ... my Tp $ 30/50. So strong Buy and Hold. WebJun 23, 2024 · The WHO has given approvals to the Pfizer/BioNTech vaccine for emergency use on 31 December, 2024. The AstraZeneca/Oxford COVID-19 vaccine got its approvals on 15 February, and the COVID-19 vaccine Ad26.COV2.S developed by Janssen (a subsidiary of Johnson & Johnson) was approved on 12 March. changed bank holiday
Ocugen, Inc. (OCGN) Latest Stock News & Headlines - Yahoo …
WebOcugen, Inc. (NASDAQ:OCGN) Q4 2024 Earnings Call Transcript February 28, 2024 Operator: Good morning and welcome to Ocugen’s Fourth Quarter and Full Year 2024 Financial Results and Business ... WebOct 15, 2024 · On Tuesday, OCGN stock surged 18% on heavy trading volume. Traders bought on shares on the news that Covaxin gained emergency use approval for 2 to 18-year-olds in India. On the face of it,... WebSep 14, 2024 · The current weakness in broader markets is also affecting penny stocks like Ocugen (NASDAQ:OCGN), which is working on treatments for rare eye diseases.On … changed band